Anesthetic management of cesarean section in cases of placenta accreta, with versus without abdominal aortic balloon occlusion: study protocol for a randomized controlled trial

被引:6
|
作者
Chu, Qinjun [1 ]
Shen, Dan [1 ]
He, Long [1 ]
Wang, Hongwei [1 ]
Zhao, Xianlan [2 ]
Chen, Zhimin [2 ]
Wang, Yanli [3 ]
Zhang, Wei [1 ]
机构
[1] Zhengzhou Univ, Dept Anesthesiol, Affiliated Hosp 1, Jian She Dong Lu 1, Zhengzhou 450052, Henan Province, Peoples R China
[2] Zhengzhou Univ, Dept Obstet, Affiliated Hosp 1, Jian She Dong Lu 1, Zhengzhou 450052, Henan Province, Peoples R China
[3] Zhengzhou Univ, Dept Intervent Radiol, Affiliated Hosp 1, Jian She Dong Lu 1, Zhengzhou 450052, Henan Province, Peoples R China
来源
TRIALS | 2017年 / 18卷
关键词
Placenta accreta; Cesarean section; Massive hemorrhage; Abdominal aortic balloon occlusion; Randomized controlled trial; SEVERE POSTPARTUM HEMORRHAGE; UTERINE ARTERY EMBOLIZATION; INTERNAL ILIAC ARTERIES; MASSIVE HEMORRHAGE; PREVIA ACCRETA; PERCRETA; HYSTERECTOMY; FLUOROSCOPY; PREGNANCIES; CATHETER;
D O I
10.1186/s13063-017-1977-5
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Placenta accreta (PA), a severe complication during delivery, is closely linked with massive hemorrhage which could endanger the lives of both mother and baby. Moreover, the incidence of PA has increased dramatically with the increasing rate of cesarean deliveries in the past few decades. Therefore, studies evaluating the effects of different perioperative managements based on different modalities in the treatment of PA are necessary. Among the numerous treatment measures, prophylactic abdominal aortic balloon occlusion (AABO) in combination with cesarean section for PA seems to be more advantageous than others. However, up to now, all studies on AABO were almost retrospective. Current evidence is insufficient to recommend for or against routinely using the AABO technology for control intraoperative hemorrhage in patients with PA. Thus, we hope to carry out a prospective, randomized controlled trial (RCT) study to confirm the effectiveness of the AABO technology in patients with PA. Methods/design: This trial is an investigator-initiated, prospective RCT that will test the superiority of AABO in combination with cesarean section compared to the traditional hysterectomy following cesarean section for parturients with PA. A total of 170 parturients with PA undergoing cesarean section will be randomized to receive either AABO in combination with cesarean section or the traditional hysterectomy following cesarean section. The primary outcome is estimated blood loss. The most important secondary outcome is the occurrence of cesarean hysterectomy during delivery; others include blood transfusion volume, operating time, neonate's Apgar scores (collected at 1, 5 and 10 min), length of stay in intensive care unit, total hospital stay, and balloon occlusion-relative data. Discussion: This prospective trial will test the superiority of AABO in combination with cesarean section compared to the traditional hysterectomy following cesarean section for parturients with PA. It may provide strong evidence about the benefits and risks of AABO in combination with cesarean section for parturients with PA.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Prior balloon valvuloplasty versus DIRECT transcatheter Aortic Valve Implantation (DIRECTAVI): study protocol for a randomized controlled trial
    Leclercq, Florence
    Robert, Pierre
    Labour, Jessica
    Lattuca, Benoit
    Akodad, Mariama
    Macia, Jean-Christophe
    Gervasoni, Richard
    Roubille, Francois
    Gandet, Thomas
    Schmutz, Laurent
    Nogue, Erika
    Nagot, Nicolas
    Albat, Bernard
    Cayla, Guillaume
    TRIALS, 2017, 18
  • [32] Diathermy versus scalpel in transverse abdominal incision in women undergoing repeated cesarean section: A randomized controlled trial
    Elbohoty, Ahmed E. H.
    Gomaa, Mostafa F.
    Abdelaleim, Mohamed
    Abd-El-Gawad, Magdi
    Elmarakby, Mohamed
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2015, 41 (10) : 1541 - 1546
  • [33] Manual removal versus spontaneous delivery of the placenta at cesarean section in developing countries: a randomized controlled trial and review of literature
    Kamel, Ahmed
    El-Mazny, Akmal
    Salah, Emad
    Ramadan, Wafaa
    Hussein, Ahmed M.
    Hany, Ayman
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2018, 31 (24): : 3308 - 3313
  • [34] Inositol in the MAnaGemENt of abdominal aortic aneurysm (IMAGEN): study protocol for a randomised controlled trial
    Sophie E. Rowbotham
    Jenna L. Pinchbeck
    Georgina Anderson
    Bernie Bourke
    Michael Bourke
    T. Christian Gasser
    Rene Jaeggi
    Jason S. Jenkins
    Corey S. Moran
    Susan K. Morton
    Christopher M. Reid
    Ramesh Velu
    Lisan Yip
    Joseph V. Moxon
    Jonathan Golledge
    Trials, 18
  • [35] Fenofibrate in the management of AbdoMinal aortic anEurysm (FAME): study protocol for a randomised controlled trial
    Rowbotham, Sophie E.
    Cavaye, Doug
    Jaeggi, Rene
    Jenkins, Jason S.
    Moran, Corey S.
    Moxon, Joseph V.
    Pinchbeck, Jenna L.
    Quigley, Frank
    Reid, Christopher M.
    Golledge, Jonathan
    TRIALS, 2017, 18
  • [36] Fenofibrate in the management of AbdoMinal aortic anEurysm (FAME): study protocol for a randomised controlled trial
    Sophie E. Rowbotham
    Doug Cavaye
    Rene Jaeggi
    Jason S. Jenkins
    Corey S. Moran
    Joseph V. Moxon
    Jenna L. Pinchbeck
    Frank Quigley
    Christopher M. Reid
    Jonathan Golledge
    Trials, 18
  • [37] Inositol in the MAnaGemENt of abdominal aortic aneurysm (IMAGEN): study protocol for a randomised controlled trial
    Rowbotham, Sophie E.
    Pinchbeck, Jenna L.
    Anderson, Georgina
    Bourke, Bernie
    Bourke, Michael
    Gasser, T. Christian
    Jaeggi, Rene
    Jenkins, Jason S.
    Moran, Corey S.
    Morton, Susan K.
    Reid, Christopher M.
    Velu, Ramesh
    Yip, Lisan
    Moxon, Joseph V.
    Golledge, Jonathan
    TRIALS, 2017, 18
  • [38] TElmisartan in the management of abDominal aortic aneurYsm (TEDY): The study protocol for a randomized controlled trial (vol 16, 274, 2015)
    Morris, Dylan R.
    Cunningham, Margaret A.
    Ahimastos, Anna A.
    Kingwell, Bronwyn A.
    Pappas, Elise
    Bourke, Michael
    Reid, Christopher M.
    Stijnen, Theo
    Dalman, Ronald L.
    Aalami, Oliver O.
    Lindeman, Jan H.
    Norman, Paul E.
    Walker, Philip J.
    Fitridge, Robert
    Bourke, Bernie
    Dear, Anthony E.
    Pinchbeck, Jenna
    Jaeggi, Rene
    Golledge, Jonathan
    TRIALS, 2016, 17
  • [39] Mesenchymal stem cells in the treatment of Cesarean section skin scars: study protocol for a randomized, controlled trial
    Dazhi Fan
    Qing Xia
    Shuzhen Wu
    Shaoxin Ye
    Li Liu
    Wen Wang
    Xiaoling Guo
    Zhengping Liu
    Trials, 19
  • [40] Mesenchymal stem cells in the treatment of Cesarean section skin scars: study protocol for a randomized, controlled trial
    Fan, Dazhi
    Xia, Qing
    Wu, Shuzhen
    Ye, Shaoxin
    Liu, Li
    Wang, Wen
    Guo, Xiaoling
    Liu, Zhengping
    TRIALS, 2018, 19